lutein
AssetAlso called Nutritional beverage fortified with 6mg lutein/day, FloraGlo lutein, INS NO.161B, E 161
Carotenoid supplementation supports antioxidant activity in retinal and neural tissues.
- Stage
- Phase 2
- Modality
- Supplement
- Target
- Not known
- 1
- Indication
- 13
- Trials
- 1
- Developer
Indications
2No named disease
Phase 2, Completed, NCT02257801, clinicaltrials.gov, Oct 23, 2026
Mild cognitive impairment
Clinical, no phase, Unknown, NCT02023645, clinicaltrials.gov, Oct 31, 2026
In the full profile
- Owner and partners1
- Trials13
- Evidence for its targets1
- Competitors3
- Aging relevance1
- Signals15
Every asset’s record: target, stage, trials and the evidence behind it.